interleukin-13 PE38QQR immunotoxin
Term · Oncology and biomedicine · MLC-T-ONC-004368
A substance being studied in the treatment of cancer. It is made by combining interleukin-13 with a toxin from Pseudomonas bacteria. It is a type of recombinant chimeric protein.
| Identifier | MLC-T-ONC-004368 |
|---|---|
| Field | Oncology and biomedicine |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-004368",
"term": "interleukin-13 PE38QQR immunotoxin",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of cancer. It is made by combining interleukin-13 with a toxin from Pseudomonas bacteria. It is a type of recombinant chimeric protein.",
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/interleukin-13-pe38qqr-immunotoxin/"
}
Record 9,337 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.